Gemina Laboratories Ltd. (TSE:GLAB) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Gemina Laboratories Ltd. has inked a landmark license agreement with a major global diagnostics company, marking a significant milestone in the commercialization of their intellectual property. This deal, which remains confidential, showcases the industry’s confidence in Gemina’s technology that has potential to save the lateral flow industry billions. The company is now pursuing additional licensing agreements to further leverage their cost-saving diagnostic technologies across various markets.
For further insights into TSE:GLAB stock, check out TipRanks’ Stock Analysis page.